AA
EBACW

Ancora Advisors’s European Biotech Acquisition Corp. Warrant EBACW Stock Holding History

Ancora Advisors’s Portfolio EBACW Stock Details EBACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,332
Closed -$1K – 2222
2022
Q4 		$1K Hold
2,332
– – ﹤0.01% 1763
2022
Q3 		$0 Hold
2,332
– – ﹤0.01% 2388
2022
Q2 		$0 Hold
2,332
– – ﹤0.01% 2548
2022
Q1 		$0 Hold
2,332
– – ﹤0.01% 2721
2021
Q4 		$1K Hold
2,332
– – ﹤0.01% 2329
2021
Q3 		$1K Hold
2,332
– – ﹤0.01% 2164
2021
Q2 		$2K Buy
+2,332
New +$2.17K ﹤0.01% 1851

Ancora Advisors's EBACW Position: Q1 2023 in Review

Ancora Advisors sold out of European Biotech Acquisition Corp. Warrant (EBACW) in Q1 2023, closing a stake of 2,332 shares — an estimated $1K sold.

Ancora Advisors first reported a position in EBACW in Q2 2021 and held it in 7 quarters. The position peaked at $2K in Q2 2021. 0 funds tracked by Wall St. Rank hold EBACW as of Q1 2023.

  • Ancora Advisors reported no remaining European Biotech Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
  • Ancora Advisors sold 2,332 European Biotech Acquisition Corp. Warrant shares in Q1 2023, an estimated $1K.
  • Ancora Advisors first reported a position in European Biotech Acquisition Corp. Warrant in Q2 2021 and held it in 7 quarters.
  • Ancora Advisors's European Biotech Acquisition Corp. Warrant position peaked at $2K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Warrant as of Q1 2023.

Based on Ancora Advisors's 13F filing for Q1 2023, filed 16 May 2023.